Your browser doesn't support javascript.
loading
Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia.
Wakita, Satoshi; Sakaguchi, Masahiro; Oh, Iekuni; Kako, Shinichi; Toya, Takashi; Najima, Yuho; Doki, Noriko; Kanda, Junya; Kuroda, Junya; Mori, Shinichiro; Satake, Atsushi; Usuki, Kensuke; Ueki, Toshimitsu; Uoshima, Nobuhiko; Kobayashi, Yutaka; Kawata, Eri; Tajika, Kenji; Nagao, Yuhei; Shono, Katsuhiro; Shibusawa, Motoharu; Tadokoro, Jiro; Kayamori, Kensuke; Hagihara, Masao; Uchiyama, Hitoji; Uchida, Naoyuki; Kubota, Yasushi; Kimura, Shinya; Nagoshi, Hisao; Ichinohe, Tatsuo; Kurosawa, Saiko; Motomura, Sayuri; Hashimoto, Akiko; Muto, Hideharu; Sato, Eriko; Ogata, Masao; Mitsuhashi, Kenjiro; Ando, Jun; Marumo, Atsushi; Omori, Ikuko; Fujiwara, Yusuke; Terada, Kazuki; Yui, Shunsuke; Arai, Kunihito; Kitano, Tomoaki; Miyata, Miho; Kurosawa, Akiyo; Mizoguchi, Ayumi; Komatsu, Norio; Fukuda, Takahiro; Ohashi, Kazuteru.
Affiliation
  • Wakita S; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Sakaguchi M; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Oh I; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Kako S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Toya T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Najima Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kuroda J; Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Mori S; Hemato-Oncology Department, St. Luke's International Hospital, Tokyo, Japan.
  • Satake A; First Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
  • Usuki K; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
  • Ueki T; Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan.
  • Uoshima N; Department of Hematology, Japanese Red Cross, Kyoto Daini Hospital, Kyoto, Japan.
  • Kobayashi Y; Department of Hematology, Japanese Red Cross, Kyoto Daini Hospital, Kyoto, Japan.
  • Kawata E; Department of Hematology, Matsushita Memorial Hospital, Osaka, Japan.
  • Tajika K; Department of Hematology, Yokohama Minami Kyousai Hospital, Kanagawa, Japan.
  • Nagao Y; Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan.
  • Shono K; Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan.
  • Shibusawa M; Department of Hematology, IMS Group Shinmatsudo Central General Hospital, Chiba, Japan.
  • Tadokoro J; Department of Hematology, IMS Group Shinmatsudo Central General Hospital, Chiba, Japan.
  • Kayamori K; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Hagihara M; Department of Hematology, Eiju General Hopital, Tokyo, Japan.
  • Uchiyama H; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan.
  • Kubota Y; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
  • Kimura S; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
  • Nagoshi H; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Kurosawa S; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Motomura S; Department of Hematology, Tama-Hokubu Medical Center, Tokyo Metropolitan Health and Medical Treatment Corporation, Tokyo, Japan.
  • Hashimoto A; Department of Immunology and Hematology, Kobe City Nishi-Kobe Medical Center, Hyogo, Japan.
  • Muto H; Division of Hematology, Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan.
  • Sato E; Department of Hematology, Juntendo University Nerima Hospital, Tokyo, Japan.
  • Ogata M; Department of Hematology, Oita University Hospital, Oita, Japan.
  • Mitsuhashi K; Department of Hematology, Saitama Red Cross Hospital, Saitama, Japan; and.
  • Ando J; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
  • Marumo A; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Omori I; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Fujiwara Y; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Terada K; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Yui S; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Arai K; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Kitano T; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Miyata M; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Kurosawa A; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Mizoguchi A; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Komatsu N; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
  • Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Ohashi K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Blood Adv ; 6(1): 238-247, 2022 01 11.
Article de En | MEDLINE | ID: mdl-34448807
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie aigüe myéloïde / Protéines liant les séquences stimulatrices de type CCAAT Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Aged / Humans Langue: En Journal: Blood Adv Année: 2022 Type de document: Article Pays d'affiliation: Japon
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie aigüe myéloïde / Protéines liant les séquences stimulatrices de type CCAAT Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Aged / Humans Langue: En Journal: Blood Adv Année: 2022 Type de document: Article Pays d'affiliation: Japon